Greetings, and welcome to the ClearPoint Neuro, Inc. Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this con ...

DYNAMIKA™ delivers SOC 2 Type II–certified, AI‑driven imaging workflows, giving pharma and biotech secure, compliant ...

In the third phase, the Diagnostics Accelerator will support the development of multi-marker panels leveraging digital and AI tools that can accelerate precision treatments.

DA, FBI, and U.S. Department of Health & Human Services, Office of the Inspector General, Shut Down Medical Center Committing Healthcare Fraud . More Than $11 Million Billed for N ...

The test allows for quantitative measurement of the protein neurofilament light chain – a marker of neuroaxonal injury – in plasma and serum.

A recent study shows that combining magnetic brain scans with computer models can safely measure how dementia medications affect living human brains. This approach could replace invasive tests and ...

Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...

New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep ...

LITTLE ROCK, AR - March 16, 2026 - PRESSADVANTAGE - Restoration Health Chiropractic has highlighted the professional ...